Shares of International Biotechnology (LON:IBT – Get Free Report) passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 657.05 ($8.59) and traded as high as GBX 687.95 ($9.00). International Biotechnology shares last traded at GBX 678 ($8.87), with a volume of 95,411 shares.
International Biotechnology Trading Up 0.6 %
The company has a market cap of £250.59 million, a PE ratio of 1,412.50 and a beta of 0.21. The business’s 50-day simple moving average is GBX 680.91 and its 200-day simple moving average is GBX 657.05. The company has a current ratio of 0.46, a quick ratio of 0.32 and a debt-to-equity ratio of 9.66.
International Biotechnology Increases Dividend
The firm also recently declared a dividend, which was paid on Friday, August 23rd. Stockholders of record on Thursday, July 25th were issued a dividend of GBX 14.50 ($0.19) per share. The ex-dividend date of this dividend was Thursday, July 25th. This represents a dividend yield of 2.28%. This is an increase from International Biotechnology’s previous dividend of $13.90. International Biotechnology’s dividend payout ratio (DPR) is currently 6,041.67%.
Insider Activity
International Biotechnology Company Profile
International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments.
Read More
- Five stocks we like better than International Biotechnology
- The Most Important Warren Buffett Stock for Investors: His Own
- 3 Leveraged ETFs to Multiply Returns
- Upcoming IPO Stock Lockup Period, Explained
- A Tale of Two Titans: Unveiling the Value in Baidu and JD.com
- What is the S&P/TSX Index?
- Is the AI-Capable iPhone 16 the Start of a Sales Super-Cycle?
Receive News & Ratings for International Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.